Using PD-L1 for immunotherapy?
Posted: 21 September 2016 | Abcam | No comments yet
PD-L1 [28-8] (ab205921) is an ideal tool to quantify PD-L1 expression in patients for PD-1 based therapies….
PD-L1 [28-8] (ab205921) is an ideal tool to quantify PD-L1 expression in patients for PD-1 based therapies.
Our PD-L1 [28-8] antibody have been extensively validated and the protocols have been optimized for use in the following popular automated IHC platforms to get the best results:
- BioGenex i6000
- Leica BOND RX
- Ventana Ultra
- Dako Omnis
Download the protocol for your platform for rapid implementation in your research.
Related topics
Antibodies, Immunotherapy
Related organisations
Abcam
